Johansen Karin, Khodakaram Kaveh, Lundgren Linda, Hasselgren Kristina, Gasslander Thomas, Sandström Per, Bratlie Svein Olav, Björnsson Bergthor
From the Department of Surgery, Linköping University, Linköping, Sweden.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Ann Surg Open. 2021 Aug 13;2(3):e090. doi: 10.1097/AS9.0000000000000090. eCollection 2021 Sep.
This study aimed to explore a possible relationship between preoperative biliary drainage (PBD) and overall survival in a national cohort of Swedish patients who underwent pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).
PBD has been shown to increase postoperative complications after PD, but its use is steadily increasing. There are a few small studies that have indicated that PBD might in itself negatively affect overall survival after PD.
Patients from the Swedish National Registry for tumors in the pancreatic and periampullary region diagnosed from 2010 to 2019 who underwent PD for PDAC were included. Kaplan-Meier curves, log-rank tests and Cox proportional hazards analyses were performed to investigate survival.
Out of 15,818 patients in the registry, 3113 had undergone PD, of whom 1471 had a histopathological diagnosis of PDAC. Patients who had undergone PBD had significantly worse survival, but the effect of PBD disappeared in the multivariable analysis when elevated bilirubin at any time was included.
PBD does not independently influence survival after PD for PDAC, but this study implies that even a nominally increased preoperative bilirubin level might impair long-term survival.
本研究旨在探讨在瑞典全国范围内接受胰十二指肠切除术(PD)治疗胰腺导管腺癌(PDAC)的患者队列中,术前胆道引流(PBD)与总生存期之间的可能关系。
已表明PBD会增加PD术后的并发症,但其使用仍在稳步增加。有一些小型研究表明,PBD本身可能会对PD后的总生存期产生负面影响。
纳入2010年至2019年期间在瑞典国家胰腺和壶腹周围区域肿瘤登记处诊断为PDAC并接受PD治疗的患者。进行Kaplan-Meier曲线、对数秩检验和Cox比例风险分析以研究生存率。
登记处的15818名患者中,3113人接受了PD,其中1471人经组织病理学诊断为PDAC。接受PBD的患者生存率明显较差,但在多变量分析中,当纳入任何时间的胆红素升高时,PBD的影响消失。
PBD不会独立影响PDAC患者PD后的生存期,但本研究表明,即使术前胆红素水平名义上升高也可能损害长期生存。